Moleculin Biotech Reports Third Quarter 2021 Results with Dividend Authorization
The company reported financial results for the quarter ended September 30, 2021, and announced the authorization of a regular quarterly cash dividend. This dividend marks a new capital allocation policy for the company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed